Compulsory vaccination is a frequently implemented policy option for ensuring comprehensive vaccine coverage. Ongoing controversies around human papillomavirus vaccine dissemination, and suboptimal coverage, suggest the value of assessing acceptability of compulsory vaccinations-particularly among likely target populations-in advance of their public availability to support evidence-informed interventions. With the first HIV vaccine to demonstrate partial efficacy in a large-scale clinical trial, we examined individual characteristics and attitudes associated with support for compulsory HIV vaccination policy among a diverse, representative sample of adults attending probable HIV vaccine dissemination venues in a large urban county. Particip...
BACKGROUND: A vaccine could substantially impact the HIV epidemic, but inadequate uptake is a seriou...
Developing and disseminating a preventive HIV vaccine is a primary scientific and public health obje...
An HIV vaccine, once it becomes available, could reduce vulnerability to HIV among African-American ...
Compulsory vaccination is a frequently implemented policy option for ensuring comprehensive vaccine ...
This is an accepted manuscript published in Prevention Science by Springer Verlag in 2014.Compulsory...
BackgroundDecade-long delays in successful implementation of Hepatitis B vaccines and ongoing obstac...
ObjectiveTo assess HIV vaccine acceptability among high-risk adults in Los Angeles.Study settingSexu...
This is an accepted manuscript of an article published in Vaccine by Elsevier in 2014.Decade-long de...
This investigation explored commonalities and differences in barriers and motivators to HIV vaccine ...
This is an accepted manuscript of an article published in Vaccine by Elsevier in 2006.HIV vaccines o...
HIV-positive patients suffer disproportionate burden of anal cancer, a disease which is primarily ca...
ObjectivesTo assess willingness to participate (WTP) in hypothetical Phase III preventive HIV vaccin...
Full list of author information is available at the end of the articlebility that an HIV vaccine is ...
This is the accepted manuscript of an article published in AIDS care by Taylor & Francis in 2008.The...
This study assessed various factors that may contribute to the likelihood of getting vaccinated for ...
BACKGROUND: A vaccine could substantially impact the HIV epidemic, but inadequate uptake is a seriou...
Developing and disseminating a preventive HIV vaccine is a primary scientific and public health obje...
An HIV vaccine, once it becomes available, could reduce vulnerability to HIV among African-American ...
Compulsory vaccination is a frequently implemented policy option for ensuring comprehensive vaccine ...
This is an accepted manuscript published in Prevention Science by Springer Verlag in 2014.Compulsory...
BackgroundDecade-long delays in successful implementation of Hepatitis B vaccines and ongoing obstac...
ObjectiveTo assess HIV vaccine acceptability among high-risk adults in Los Angeles.Study settingSexu...
This is an accepted manuscript of an article published in Vaccine by Elsevier in 2014.Decade-long de...
This investigation explored commonalities and differences in barriers and motivators to HIV vaccine ...
This is an accepted manuscript of an article published in Vaccine by Elsevier in 2006.HIV vaccines o...
HIV-positive patients suffer disproportionate burden of anal cancer, a disease which is primarily ca...
ObjectivesTo assess willingness to participate (WTP) in hypothetical Phase III preventive HIV vaccin...
Full list of author information is available at the end of the articlebility that an HIV vaccine is ...
This is the accepted manuscript of an article published in AIDS care by Taylor & Francis in 2008.The...
This study assessed various factors that may contribute to the likelihood of getting vaccinated for ...
BACKGROUND: A vaccine could substantially impact the HIV epidemic, but inadequate uptake is a seriou...
Developing and disseminating a preventive HIV vaccine is a primary scientific and public health obje...
An HIV vaccine, once it becomes available, could reduce vulnerability to HIV among African-American ...